(Total Views: 613)
Posted On: 10/16/2020 6:23:44 AM
Post# of 72433
If I am Gilead, I would be all over securing B for my combo trial with Remdesivir. They only have a $78B market cap though, so maybe they can't afford IPIX
(8)
(1)